Pregled bibliografske jedinice broj: 1224786
Urinary brain-derived neurotrophic factor and nerve growth factor as noninvasive biomarkers of overactive bladder in children
Urinary brain-derived neurotrophic factor and nerve growth factor as noninvasive biomarkers of overactive bladder in children // Biochemia medica, 32 (2022), 3; 030706, 9 doi:10.11613/bm.2022.030706 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1224786 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Urinary brain-derived neurotrophic factor and
nerve growth factor as noninvasive biomarkers of
overactive bladder in children
Autori
Čolić, Merima ; Rogić, Dunja ; Leniček Krleža, Jasna ; Kozmar, Ana ; Stemberger Marić, Lorna ; Abdović, Slaven
Izvornik
Biochemia medica (1330-0962) 32
(2022), 3;
030706, 9
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
biomarker ; brain-derived neurotrophic factor ; child ; nerve growth factor ; overactive bladder
Sažetak
Abstract Introduction Overactive bladder (OAB) is the most common urinary disorder and the leading cause of functional daytime intermittent urinary incontinence in children. The aim of this study was to determine whether urinary brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) concentrations, normalized to urine creatinine, could be used as biomarkers for diagnosis and treatment monitoring of OAB in children. Materials and methods Urine samples of 48 pediatric patients with OAB were collected at the start of anticholinergic therapy (baseline), at follow-up visits (3 and 6 months), and from 48 healthy controls. Urinary BDNF and NGF concentrations were determined by ELISA method (Merck, Darmstadt, Germany) and Luminex method (Thermo Fisher Scientific, Waltham, USA). Differences of frequency between quantifiable analyte concentrations between subject groups were determined using Fisher’s exact test. Results There was no statistically significant difference between quantifiable analyte concentrations between patients at baseline and the control group for BDNF and NGF by either the ELISA or Luminex method (P = 1.000, P = 0.170, P = 1.000, and P = N/A, respectively). There was a statistically significant difference between quantifiable BDNF by the ELISA method between patients at baseline and complete success follow-up (P = 0.027), while BDNF by Luminex method and NGF by both methods were not statistically significant (P = 0.078, P = 0.519, and P = N/A, respectively). Conclusions This study did not demonstrate that urinary BDNF and NGF concentrations, can be used as biomarkers for diagnosis and therapy monitoring of OAB in children.
Izvorni jezik
Engleski
Znanstvena područja
Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Projekti:
UIP-2017-05-5379 - Uloga urinarnih biomarkera u prekomjerno aktivnom mokraćnom mjehuru u djece (pOAB) (Abdović, Slaven, HRZZ - 2017-05) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za infektivne bolesti "Dr Fran Mihaljević",
Klinički bolnički centar Zagreb,
Klinika za dječje bolesti
Profili:
Ana Kozmar
(autor)
Merima Čolić
(autor)
Dunja Rogić
(autor)
Slaven Abdović
(autor)
Jasna Leniček Krleža
(autor)
Lorna Stemberger Marić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE